Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity
Clinical trial NCT04815967 · TERMINATED
Trial details
- NCT number
- NCT04815967
- Sponsor
- Solstice Neurosciences, LLC, a subsidiary of MDD US Operations, LLC
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-02
- Primary completion
- 2023-04-23
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.